MIST

MKT CAP:$169M

Milestone Pharmaceuticals Inc

Market Cap

$169M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.23-$0.82 (-40.00%)

Jun 5, 2026

52W High $2.9552W Low $1.01

Company Details

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medicatio...

CEO

—

IPO Date

May 9, 2019

Website

www.milestonepharma.com

Key Metrics TTM

Revenue

$2M

+1551.9% YoY

Net Income

-$68M

EPS (Diluted)

Free Cash Flow

-$51M

Revenue / Share

$0.01

Gross Margin

93.1%

Operating Margin

-3669.4%

Net Margin

-3832.0%

FCF Margin

-2871.8%

P/S

94.9x

P/E

Earnings Reports

Q1 2026

May 13, 2026

$238.0K

FY 2025

Mar 20, 2026

$2M

Q4 2025

Mar 20, 2026

$2M+1331.5%

Q3 2025

Nov 12, 2025

Q2 2025

Aug 12, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee